Incyte’s The Power of Choice campaign was supported by two 2025 MM+M Agency 100 honorees: Klick and Real Chemistry.

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...

Teva Pharmaceuticals TEVA announced a funding agreement with Royalty Pharma plc RPRX, under which the latter will provide up ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 ...

Teva and Royalty Pharma have signed a deal worth up to $500 million to advance TEV-408, a drug being tested for vitiligo and ...

Vitiligo, affecting millions globally, extends beyond cosmetic concerns to deeply impact mental health and social acceptance. The condition triggers emotional distress, fueled by cultural stigma and ...

Vitiligo is a skin condition that causes areas of the skin to lose color or pigmentation. It’s not contagious and can occur on any part of the body. About 1.4% of adults in the United States have been ...

Kim Kardashian, 43, revealed this week that one of her two sons — Saint, 8, or Psalm, 5 — has the rare skin condition vitiligo. While discussing her psoriasis journey on Monday’s episode of the “She ...

Vitiligo causes light or white patches to form on the skin. It can affect anyone but is often more noticeable in Black people and those with darker skin tones. This can lead to other issues, such as ...

There is an autoimmune link between certain types of vitiligo and autoimmune thyroid disease. However, the exact basis of this connection is unclear. People with a specific type of vitiligo are more ...